Judge Rules Case About Sharing Health Data With Google and Meta May Continue
A case alleging discount prescription drug platform GoodRx unlawfully shared patients' protected health information with Google and Meta will continue, a federal judge ruled Tuesday.
Sign up for a free preview to unlock the rest of this article
Privacy Daily provides accurate coverage of newsworthy developments in data protection legislation, regulation, litigation, and enforcement for privacy professionals responsible for ensuring effective organizational data privacy compliance.
Judge Araceli Martinez-Olguin said the plaintiffs allege GoodRx "knew the incorporation of their tracking technologies on websites and mobile apps resulted in the interception of sensitive health information, that they did not take any steps to prevent the interception of this data, that this conduct was intentional despite knowing about the resulting privacy violations ... ." Moreover, the judge said, GoodRx made billions in advertising revenue on information the tracking tech intercepted.
Additionally, "a reasonable user reading" GoodRx's privacy policy "would reasonably think they were not consenting to the sharing and interception of sensitive medical information," Martinez-Olguin said. GoodRx argued that consumers gave it consent.
She also denied a motion to dismiss on statute of limitations grounds in case 23-00501.
However, Martinez-Olguin dismissed the plaintiffs' claims related to aiding and abetting and violating some sections of the California Civil Code.
The complaints, filed in 2023, were consolidated into Doe v. GoodRx (see 2305040079).